CKPT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Checkpoint Therapeutics Inc (CKPT).


$156.26M Market Cap.

As of 03/31/2025 5:00 PM ET (MRY) • Disclaimer

CKPT Market Cap. (MRY)


CKPT Shares Outstanding (MRY)


CKPT Assets (MRY)


Total Assets

$7.47M

Total Liabilities

$20.10M

Total Investments

$0

CKPT Income (MRY)


Revenue

$41.00K

Net Income

-$56.24M

Operating Expense

$56.22M

CKPT Cash Flow (MRY)


CF Operations

-$31.10M

CF Investing

$0

CF Financing

$32.78M

CKPT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CKPT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$7,471,000 (38.92%)

$5,378,000 (-59.53%)

$13,290,000 (-76.15%)

$55,728,000 (30.83%)

Assets Current

$7,471,000 (38.92%)

$5,378,000 (-59.53%)

$13,290,000 (-76.15%)

$55,728,000 (30.83%)

Assets Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$12,625,000 (3.23%)

-$13,047,000 (33.03%)

-$19,483,000 (-165.50%)

$29,746,000 (-15.92%)

Property Plant & Equipment Net

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cash & Equivalents

$6,604,000 (34.01%)

$4,928,000 (-59.16%)

$12,068,000 (-77.95%)

$54,735,000 (34.25%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$73,000 (329.41%)

$17,000 (-15.00%)

Trade & Non-Trade Payables

$19,898,000 (8.73%)

$18,300,000 (-15.29%)

$21,603,000 (-16.85%)

$25,982,000 (260.01%)

Accumulated Retained Earnings (Deficit)

-$370,573,000 (-17.89%)

-$314,333,000 (-19.75%)

-$262,486,000 (-31.33%)

-$199,862,000 (-39.58%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Liabilities

$20,096,000 (9.07%)

$18,425,000 (-43.78%)

$32,773,000 (26.14%)

$25,982,000 (260.01%)

Liabilities Current

$20,096,000 (9.07%)

$18,425,000 (-43.78%)

$32,773,000 (26.14%)

$25,982,000 (260.01%)

Liabilities Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

CKPT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$41,000 (-60.19%)

$103,000 (-46.35%)

$192,000 (-28.36%)

$268,000 (-74.93%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$20,063,000 (131.01%)

$8,685,000 (-0.17%)

$8,700,000 (1.90%)

$8,538,000 (7.83%)

Research & Development Expense

$36,152,000 (-17.02%)

$43,566,000 (-12.56%)

$49,825,000 (2.83%)

$48,453,000 (196.31%)

Operating Expenses

$56,215,000 (7.59%)

$52,251,000 (-10.72%)

$58,525,000 (2.69%)

$56,991,000 (134.82%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$56,240,000 (-8.47%)

-$51,847,000 (17.21%)

-$62,624,000 (-10.51%)

-$56,670,000 (-145.53%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$56,240,000 (-8.47%)

-$51,847,000 (17.21%)

-$62,624,000 (-10.51%)

-$56,670,000 (-145.53%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$56,240,000 (-8.47%)

-$51,847,000 (17.21%)

-$62,624,000 (-10.51%)

-$56,670,000 (-145.53%)

Weighted Average Shares

$39,674,444 (111.68%)

$18,742,494 (112.13%)

$8,835,521 (16.21%)

$7,603,160 (36.18%)

Weighted Average Shares Diluted

$39,674,444 (111.68%)

$18,742,494 (112.13%)

$8,835,521 (16.21%)

$7,603,160 (36.18%)

Earning Before Interest & Taxes (EBIT)

-$56,240,000 (-8.47%)

-$51,847,000 (17.21%)

-$62,624,000 (-10.51%)

-$56,670,000 (-145.53%)

Gross Profit

$41,000 (-60.19%)

$103,000 (-46.35%)

$192,000 (-28.36%)

$268,000 (-74.93%)

Operating Income

-$56,174,000 (-7.72%)

-$52,148,000 (10.60%)

-$58,333,000 (-2.84%)

-$56,723,000 (-144.49%)

CKPT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow from Financing

$32,777,000 (-18.97%)

$40,450,000 (171.71%)

$14,887,000 (-63.03%)

$40,269,000 (28.88%)

Net Cash Flow from Operations

-$31,101,000 (34.65%)

-$47,590,000 (17.31%)

-$57,554,000 (-118.79%)

-$26,306,000 (-58.94%)

Net Cash Flow / Change in Cash & Cash Equivalents

$1,676,000 (123.47%)

-$7,140,000 (83.27%)

-$42,667,000 (-405.57%)

$13,963,000 (-4.98%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$23,592,000 (-22.22%)

$30,332,000 (103.75%)

$14,887,000 (-63.03%)

$40,269,000 (21.00%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$15,252,000 (426.48%)

$2,897,000 (-0.92%)

$2,924,000 (-6.79%)

$3,137,000 (12.84%)

Depreciation Amortization & Accretion

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

CKPT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-137170.70% (-172.51%)

-50336.90% (-54.33%)

-32616.70% (-54.25%)

-21145.50% (-879.37%)

EBITDA Margin

-137170.70% (-172.51%)

-50336.90% (-54.33%)

-32616.70% (-54.25%)

-21145.50% (-879.37%)

Return on Average Equity (ROAE)

439.30% (64.22%)

267.50% (107.33%)

-3651.50% (-2940.38%)

-120.10% (-33.74%)

Return on Average Assets (ROAA)

-742.60% (21.83%)

-950.00% (-316.85%)

-227.90% (-145.58%)

-92.80% (-31.82%)

Return on Sales (ROS)

-137170.70% (-172.51%)

-50336.90% (-54.33%)

-32616.70% (-54.25%)

-21145.50% (-879.37%)

Return on Invested Capital (ROIC)

285.80% (32.99%)

214.90% (-15.89%)

255.50% (-42.14%)

441.60% (11.97%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-2.25 (-212.19%)

-0.72 (-0.14%)

-0.72 (82.73%)

-4.17 (35.42%)

Price to Sales Ratio (P/S)

3,096.54 (643.11%)

416.7 (77.20%)

235.15 (-73.35%)

882.31 (537.50%)

Price to Book Ratio (P/B)

-12.38 (-199.76%)

-4.13 (-69.22%)

-2.44 (-127.86%)

8.76 (72.25%)

Debt to Equity Ratio (D/E)

-1.59 (-12.75%)

-1.41 (16.05%)

-1.68 (-292.67%)

0.87 (327.94%)

Earnings Per Share (EPS)

-1.42 (55.21%)

-3.17 (55.29%)

-7.09 (4.83%)

-7.45 (-81.71%)

Sales Per Share (SPS)

0 (-80.00%)

0.01 (-77.27%)

0.02 (-37.14%)

0.04 (-81.68%)

Free Cash Flow Per Share (FCFPS)

-0.78 (69.12%)

-2.54 (61.02%)

-6.51 (-88.27%)

-3.46 (-16.69%)

Book Value Per Share (BVPS)

-0.32 (54.31%)

-0.7 (68.44%)

-2.21 (-156.37%)

3.91 (-38.27%)

Tangible Assets Book Value Per Share (TABVPS)

0.19 (-34.49%)

0.29 (-80.92%)

1.5 (-79.48%)

7.33 (-3.93%)

Enterprise Value Over EBIT (EV/EBIT)

-3 (-200.00%)

-1 (0%)

0 (0%)

-4 (33.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-2.69 (-168.16%)

-1 (-132.64%)

-0.43 (87.78%)

-3.54 (40.82%)

Asset Turnover

0.01 (-73.68%)

0.02 (171.43%)

0.01 (75.00%)

0 (-87.88%)

Current Ratio

0.37 (27.40%)

0.29 (-28.08%)

0.41 (-81.07%)

2.15 (-63.66%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$31,101,000 (34.65%)

-$47,590,000 (17.31%)

-$57,554,000 (-118.79%)

-$26,306,000 (-58.94%)

Enterprise Value (EV)

$151,561,000 (190.89%)

$52,102,620 (92.58%)

$27,054,617 (-86.50%)

$200,331,484 (45.31%)

Earnings Before Tax (EBT)

-$56,240,000 (-8.47%)

-$51,847,000 (17.21%)

-$62,624,000 (-10.51%)

-$56,670,000 (-145.53%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$56,240,000 (-8.47%)

-$51,847,000 (17.21%)

-$62,624,000 (-10.51%)

-$56,670,000 (-145.53%)

Invested Capital

-$19,229,000 (-6.98%)

-$17,975,000 (43.03%)

-$31,551,000 (-26.26%)

-$24,989,000 (-363.36%)

Working Capital

-$12,625,000 (3.23%)

-$13,047,000 (33.03%)

-$19,483,000 (-165.50%)

$29,746,000 (-15.92%)

Tangible Asset Value

$7,471,000 (38.92%)

$5,378,000 (-59.53%)

$13,290,000 (-76.15%)

$55,728,000 (30.83%)

Market Capitalization

$156,264,000 (190.05%)

$53,874,620 (13.34%)

$47,532,617 (-81.76%)

$260,534,484 (44.83%)

Average Equity

-$12,803,500 (33.95%)

-$19,384,750 (-1230.31%)

$1,715,000 (-96.37%)

$47,191,000 (83.63%)

Average Assets

$7,573,750 (38.78%)

$5,457,500 (-80.14%)

$27,474,750 (-55.01%)

$61,062,500 (86.26%)

Invested Capital Average

-$19,678,250 (18.44%)

-$24,126,500 (1.57%)

-$24,512,250 (-91.01%)

-$12,832,750 (-119.27%)

Shares

48,832,500 (107.57%)

23,526,035 (152.92%)

9,301,882 (11.04%)

8,377,315 (23.41%)